Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Children's Motrin OTC switch endorsed by advisory committees for fever reduction, analgesia.

Executive Summary

CHILDREN'S MOTRIN50184 RX-TO-OTC SWITCH FOR FEVER REDUCTION, ANALGESIA recommended for approval March 28 at a joint meeting of FDA's Nonprescription Drugs and Arthritis Advisory Committees. The advisory committees endorsed Johnson & Johnson's prescription ibuprofen product, Motrin Suspension, as an over-the-counter fever reducer and analgesic. McNeil currently markets the OTC children's analgesic Children's Tylenol with acetaminophen. FDA approved the analgesic indication for prescription Motrin Suspension tablets and caplets on March 24.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026010

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel